Sirona Biochem Corp. (CVE:SBM – Get Free Report)’s stock price traded down 18.8% on Monday . The stock traded as low as C$0.07 and last traded at C$0.07. 112,944 shares traded hands during trading, an increase of 44% from the average session volume of 78,445 shares. The stock had previously closed at C$0.08.
Sirona Biochem Stock Performance
The firm has a 50-day moving average price of C$0.07 and a two-hundred day moving average price of C$0.06. The company has a debt-to-equity ratio of 219.21, a current ratio of 0.34 and a quick ratio of 2.41. The firm has a market capitalization of C$16.69 million, a P/E ratio of -6.50 and a beta of -0.03.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Recommended Stories
- Five stocks we like better than Sirona Biochem
- High Flyers: 3 Natural Gas Stocks for March 2022
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- The Risks of Owning Bonds
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
